Evidence map›Paper›PMID 33738589›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2021

Treatment of chemotherapy-induced cachexia with BST204: a multimodal validation study.

Ho-Jin Kim, Su Jung Kim, Chul-Woong Woo, Sang-Tae Kim, Minju Im, Sun Kyu Park, Jeom-Yong Kim, Hyun Ju Yoo, Dong-Cheol Woo, Jeong Kon Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Anti-Colorectal Cancer Activity ofInternational journal of molecular sciences · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ho-Jin KimDepartment of Medical Science, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Su Jung KimDepartment of Convergence Medicine, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chul-Woong WooMR Core Laboratory, Asan Medical Center, Asan Medical Institute of Convergence and Technology,, Seoul, Republic of Korea.
Sang-Tae KimMR Core Laboratory, Asan Medical Center, Asan Medical Institute of Convergence and Technology,, Seoul, Republic of Korea.
Minju ImGREEN CROSS Wellbeing Co., Ltd, Seongnam, Republic of Korea.
Sun Kyu ParkGREEN CROSS Wellbeing Co., Ltd, Seongnam, Republic of Korea.
Jeom-Yong KimGREEN CROSS Wellbeing Co., Ltd, Seongnam, Republic of Korea.
Hyun Ju Yoo *Department of Convergence Medicine, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea. yoohyunju@amc.seoul.kr.
Dong-Cheol Woo *Department of Convergence Medicine, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea. dcwoo@amc.seoul.kr.ORCID http://orcid.org/0000-0001-8202-015X
Jeong Kon Kim *Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. kim.jeongkon@gmail.com.
Ulsan College · KRGreen Cross (South Korea) · KRAsan Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChemotherapy is a major etiology of cachexia. Ginseng products are known to have various anti-cachectic and health-promoting effects, such as inhibiting inflammation and promoting energy production. In particular, BST204, purified ginseng dry extract, contains multiple ginsenosides that can reduce chemotherapy-related fatigue and toxicity.

objectivesTo investigate the effects of BST204 on the alleviation of chemotherapy-induced cachexia using a multimodal approach.

methodsIn a CT26 mouse syngeneic colon cancer model, cachexia was predominantly induced by chemotherapy with 5-fluorouracil (5-FU) than by tumor growth. BST204 at a dose of 100 or 200 mg/kg was administered to 5-FU-treated mice.

resultsBST204 significantly mitigated the decrease in tumor-excluded body weight (change in 5-FU group and BST204 groups: - 13% vs. - 6% on day 7; - 30% vs. - 20% on day 11), muscle volume (- 19% vs. - 11%), and fat volume (- 91% vs. - 56%). The anti-cachectic effect of BST204 was histologically demonstrated by an improved balance between muscle regeneration and degeneration and a decrease in muscle cross-sectional area reduction.

conclusionChemotherapy-induced cachexia was biochemically and metabolically characterized by activated inflammation, enhanced oxidative stress, increased protein degradation, decreased protein stabilization, reduced glucose-mediated energy production, and deactivated glucose-mediated biosynthesis. These adverse effects were significantly improved by BST204 treatment. Overall, our multimodal study demonstrated that BST204 could effectively alleviate chemotherapy-induced cachexia.

Indexed as

Drug-Related Side Effects and Adverse ReactionsDrug TherapyAnimalsCachexiaCell Line, TumorColonic NeoplasmsDisease Models, AnimalGlucoseInflammationInterleukin-6MaleMetabolomicsMiceMice, Inbred BALB COxidative StressPlant ExtractsBST204 ginseng extractGlucoseInterleukin-6Plant ExtractsBST204Chemotherapy-induced cachexiaMultimodal study

Identifiers

PMID33738589
OpenAlexW3138956198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.